Ming Chen

发表论文 151 篇 · 总被引 3176 次 · h-index 29

代表论文

• Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial. (2022 · The Lancet Oncology · 被引 160)
• Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial. (2021 · JAMA Oncology · 被引 91)
• Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer (2021 · Clinical Cancer Research · 被引 87)
• A phase III multicenter randomized clinical trial of 60 Gy vs 50 Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma. (2022 · Clinical Cancer Research · 被引 66)
• Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer (2021 · Nature Communications · 被引 45)
• Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review (2022 · Journal of Cancer Research and Clinical Oncology · 被引 26)